We speculate that the expression of ER and AMHR2 on the surface of breast cancer cells plays a positive role in promoting apoptosis when applying anti-HER2 therapy, and the AMHR2 on the surface of breast cancer cells may be related to chemotherapeutic drug resistance. Here, ESR1 is linked to breast carcinoma.